Evidence map›Paper›PMID 24429578›Full record

ArticleDiabetologia2014

Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes.

Matthew J Butcher, Daniel Hallinger, Eden Garcia, Yui Machida, Swarup Chakrabarti, Jerry Nadler, Elena V Galkina, Yumi Imai

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 158 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Matthew J ButcherDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, 700 West Olney Road, Norfolk, VA, 23507-1696, USA.
Daniel Hallinger
Eden Garcia
Yui Machida
Swarup Chakrabarti
Jerry Nadler
Elena V Galkina
Yumi Imai
Eastern Virginia Medical School · US

Funding

Role of Lipid Droplet Proteins in Islet Function in Diabetes and ObesityR01DK090490 · NIDDK · UNIVERSITY OF IOWA · PI IMAI, YUMI · 2011 to 2025
$5.0M
Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and AtherosclerosisR01HL112605 · NHLBI · EASTERN VIRGINIA MEDICAL SCHOOL · PI NADLER, JERRY L. · 2012 to 2016
$2.0M
NHLBI NIH HHS R01 HL112605NHLBI NIH HHS R01-HL112605NIDDK NIH HHS R01 DK090490NIDDK NIH HHS R01-DK090490
6 · The paper itself

Abstract

aims/hypothesisChronic inflammation in type 2 diabetes is proposed to affect islets as well as insulin target organs. However, the nature of islet inflammation and its effects on islet function in type 2 diabetes remain unclear. Moreover, the immune cell profiles of human islets in healthy and type 2 diabetic conditions are undefined. We aimed to investigate the correlation between proinflammatory cytokine expression, islet leucocyte composition and insulin secretion in type 2 diabetic human islets.

methodsHuman islets from organ donors with or without type 2 diabetes were studied. First and second phases of glucose-stimulated insulin secretion were determined by perifusion. The expression of inflammatory markers was obtained by quantitative PCR. Immune cells within human islets were analysed by FACS.

resultsType 2 diabetic islets, especially those without first-phase insulin secretion, displayed higher CCL2 and TNFa expression than healthy islets. CD45(+) leucocytes were elevated in type 2 diabetic islets, to a greater extent in moderately functional type 2 diabetic islets compared with poorly functional ones, and corresponded with elevated ALOX12 but not with CCL2 or TNFa expression. T and B lymphocytes and CD11c(+) cells were detectable within both non-diabetic and type 2 diabetic islet leucocytes. Importantly, the proportion of B cells was significantly elevated within type 2 diabetic islets. CONCLUSIONS/

interpretationElevated total islet leucocyte content and proinflammatory mediators correlated with islet dysfunction, suggesting that heterogeneous insulitis occurs during the development of islet dysfunction in type 2 diabetes. In addition, the altered B cell content highlights a potential role for the adaptive immune response in islet dysfunction.

Indexed as

Body Mass IndexCells, CulturedChemokine CCL2Diabetes Mellitus, Type 2Flow CytometryGene Expression RegulationHumansInflammationInsulinInsulin SecretionIslets of LangerhansLeukocytesReal-Time Polymerase Chain ReactionTumor Necrosis Factor-alphaCCL2 protein, humanChemokine CCL2InsulinTNF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID24429578
PMCPMC3966210
OpenAlexW2031213748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.